Schilke Tobin - Insider Non-Derivative Transactions at Revance Therapeutics, Inc. (RVNC) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jun 30, 2024, Schilke Tobin's relationship to Revance Therapeutics, Inc. (RVNC) is Officer (CFO), and currently has 193,666 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RVNC insiders.

Data Source: SEC.
Schilke Tobin - Insider Non-Derivative Transactions of RVNC Common Stock
Schilke Tobin - Insider Non-Derivative Transactions at RVNC
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jul 1, 2024 Acquisition -- (Common Stock) 1000 2.18 193666
Mar 19, 2024 Sell -- (Common Stock) 9361 5.04 192666
Mar 16, 2024 F -- (Common Stock) 3822 5.31 202027
Mar 1, 2024 Acquisition -- (Common Stock) 17447 0 205849
Feb 1, 2024 Acquisition -- (Common Stock) 96667 0 188402
Jan 1, 2024 Acquisition -- (Common Stock) 434 7.47 91735
Aug 12, 2023 F -- (Common Stock) 11215 18.91 91301
Aug 12, 2023 Acquisition -- (Common Stock) 22620 0 102516
Jul 4, 2023 Sell -- (Common Stock) 1701 25.04 79896
Jul 1, 2023 Acquisition -- (Common Stock) 769 15.61 81597
Jun 3, 2023 Sell -- (Common Stock) 500 31 80828
Jun 2, 2023 Sell -- (Common Stock) 2701 30.57 81328
May 16, 2023 Sell -- (Common Stock) 21401 34.55 84029
May 2, 2023 Sell -- (Common Stock) 3201 31.7 63081
Apr 4, 2023 Sell -- (Common Stock) 3201 32.15 66282
Mar 16, 2023 F -- (Common Stock) 3739 30.65 69483
Mar 10, 2023 Sell -- (Common Stock) 18517 31.59 73222
Mar 2, 2023 Sell -- (Common Stock) 3201 33.5 49390
Feb 16, 2023 F -- (Common Stock) 2085 33.21 52591
Feb 2, 2023 Sell -- (Common Stock) 3201 34.6 54676
Jan 21, 2023 Sell -- (Common Stock) 1000 31 57877
Jan 10, 2023 Sell -- (Common Stock) 1000 30 58877
Jan 10, 2023 Sell -- (Common Stock) 1000 28 59877
Jan 10, 2023 Sell -- (Common Stock) 1701 25 60877
Jan 1, 2023 Acquisition -- (Common Stock) 645 12.18 62578
Sep 23, 2022 Acquisition -- (Common Stock) 42349 0 91739
Feb 3, 2022 Acquisition -- (Common Stock) 42349 0 105430